Tom Tang

1.3k total citations
19 papers, 959 citations indexed

About

Tom Tang is a scholar working on Genetics, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Tom Tang has authored 19 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 4 papers in Oncology and 4 papers in Complementary and alternative medicine. Recurrent topics in Tom Tang's work include Andrographolide Research and Applications (4 papers), Inflammatory Bowel Disease (4 papers) and Hydrocarbon exploration and reservoir analysis (3 papers). Tom Tang is often cited by papers focused on Andrographolide Research and Applications (4 papers), Inflammatory Bowel Disease (4 papers) and Hydrocarbon exploration and reservoir analysis (3 papers). Tom Tang collaborates with scholars based in United States, China and Australia. Tom Tang's co-authors include Minke E. Binnerts, Walter D. Funk, Bryan Boyle, Peter Emtage, Yi Liu, Makoto Kakitani, Kyung‐Ah Kim, Takeshi Oshima, Kazuma Tomizuka and Jingsong Zhao and has published in prestigious journals such as Science, Blood and Gastroenterology.

In The Last Decade

Tom Tang

17 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Tang United States 9 411 309 199 174 116 19 959
Ki‐Jung Yun South Korea 22 320 0.8× 60 0.2× 198 1.0× 103 0.6× 48 0.4× 47 1.1k
Lei Hou China 18 491 1.2× 252 0.8× 61 0.3× 147 0.8× 33 0.3× 46 1.1k
Ken‐ichi Inada Japan 22 446 1.1× 243 0.8× 294 1.5× 72 0.4× 32 0.3× 50 1.5k
Hatem Masmoudi Tunisia 22 276 0.7× 207 0.7× 71 0.4× 129 0.7× 29 0.3× 124 1.5k
Qiqing Huang China 14 322 0.8× 472 1.5× 145 0.7× 199 1.1× 15 0.1× 30 1.1k
Gabriela Fonseca‐Camarillo Mexico 16 265 0.6× 229 0.7× 110 0.6× 109 0.6× 17 0.1× 41 779
KyeongJin Kim South Korea 20 525 1.3× 93 0.3× 114 0.6× 595 3.4× 18 0.2× 37 1.3k
Avninder Singh India 16 188 0.5× 42 0.1× 139 0.7× 146 0.8× 76 0.7× 53 821
Hongwen Li China 17 378 0.9× 100 0.3× 285 1.4× 38 0.2× 17 0.1× 83 1.0k

Countries citing papers authored by Tom Tang

Since Specialization
Citations

This map shows the geographic impact of Tom Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Tang more than expected).

Fields of papers citing papers by Tom Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Tang. The network helps show where Tom Tang may publish in the future.

Co-authorship network of co-authors of Tom Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Tang. A scholar is included among the top collaborators of Tom Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Tang. Tom Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Desîlets, Antoine, Justin Lucas, Lisa Licitra, et al.. (2025). Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study. Targeted Oncology. 20(2). 299–310.
2.
3.
Coles, Nathan D., Hua Mo, Jeffrey E. Habben, et al.. (2024). Transgene effects vary among maize populations with implications for improving quantitative traits. Crop Science. 65(1). 1 indexed citations
4.
Cooper, Mark, Owen Powell, Carla Gho, Tom Tang, & Carlos D. Messina. (2023). Extending the breeder’s equation to take aim at the target population of environments. Frontiers in Plant Science. 14. 1129591–1129591. 21 indexed citations
5.
Tang, Tom, Wei Wang, Hao Sun, et al.. (2023). Unconventional Gas EOR: Recovery Mechanisms and Piloting. 2 indexed citations
6.
Messina, Carlos D., Fred van Eeuwijk, Tom Tang, et al.. (2022). Crop Improvement for Circular Bioeconomy Systems. Journal of the ASABE. 65(3). 491–504. 23 indexed citations
7.
Srivastava, Mayank, et al.. (2022). Impact of Brine Chemistry on Waterflood Oil Recovery: Experimental Evaluation and Recovery Mechanisms. SPE Improved Oil Recovery Conference. 1 indexed citations
8.
Arab, Juan Pablo, Tejasav S. Sehrawat, Douglas A. Simonetto, et al.. (2019). An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis. Hepatology. 72(2). 441–453. 143 indexed citations
9.
Liu, Xingcun, Xiaohong Wu, Kai Huang, et al.. (2019). Molecular mutation characteristics of mismatch and homologous recombination repair genes in gastrointestinal cancer. Oncology Letters. 18(3). 2789–2798. 3 indexed citations
10.
Cao, Junning, Zhongyu Yuan, Cheng Huang, et al.. (2015). Phase Ib Studies of Benegrastim in Chinese Women with Breast Cancer Receiving Myelotoxic Chemotherapy. Blood. 126(23). 4601–4601. 1 indexed citations
11.
12.
Sandborn, William J., Stephan R. Targan, Vera S. Byers, et al.. (2012). Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis. The American Journal of Gastroenterology. 108(1). 90–98. 115 indexed citations
13.
Tang, Tom, et al.. (2010). Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Alimentary Pharmacology & Therapeutics. 33(2). 194–202. 88 indexed citations
14.
Sandborn, William J., Stephan R. Targan, Vera S. Byers, Xiaoqiang Yan, & Tom Tang. (2010). 847x Double Blind Placebo Controlled Phase IIB Trial of HMPL-004 (Andrographis Paniculata Extract) in Active Mild to Moderate Ulcerative Colitis (UC). Gastroenterology. 138(5). S–115. 2 indexed citations
15.
Sandborn, William J., Stephan Targan, Vera S. Byers, & Tom Tang. (2010). Randomized, Double-blind, Placebo-Controlled Trial of Andrographis Paniculata Extract (HMPL-004) in Patients with Moderately Active Crohnʼs Disease. The American Journal of Gastroenterology. 105. S429–S430. 2 indexed citations
16.
Kim, Kyung‐Ah, Makoto Kakitani, Jingsong Zhao, et al.. (2005). Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium. Science. 309(5738). 1256–1259. 449 indexed citations
17.
Binnerts, Minke E., Xiaohui Wen, Kirsten Canté-Barrett, et al.. (2004). Human Crossveinless-2 is a novel inhibitor of bone morphogenetic proteins. Biochemical and Biophysical Research Communications. 315(2). 272–280. 67 indexed citations
18.
Nathwani, Dilip, Jim Z. Li, Richard J. Willke, et al.. (2004). An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects. International Journal of Antimicrobial Agents. 23(4). 315–324. 19 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ki‐Jung Yun Breakdown of academic impact, for papers by Lei Hou Breakdown of academic impact, for papers by Ken‐ichi Inada Breakdown of academic impact, for papers by Hatem Masmoudi Breakdown of academic impact, for papers by Qiqing Huang Breakdown of academic impact, for papers by Gabriela Fonseca‐Camarillo Breakdown of academic impact, for papers by KyeongJin Kim Breakdown of academic impact, for papers by Avninder Singh Breakdown of academic impact, for papers by Hongwen Li
Rankless by CCL
2026